XML 51 R40.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SCHEDULE OF INVESTMENTS (Details) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023
--- | --- | ---
Cost method investment | $ 3,084,278 | $ 3,084,278
Direct Dermatology Inc. [Member] |  |
Cost method investment | 1,000,000 | 1,000,000
Pixalere Healthcare Inc. [Member] |  |
Cost method investment | $ 2,084,278 | $ 2,084,278

X
- Definition Includes other investments and securities that are not at fair value as of the balance sheet date and those that are not accounted for under the equity method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_OtherInvestmentsAndSecuritiesAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | dei_LegalEntityAxis=SMTI_DirectDermatologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=SMTI_PixalereHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |